iBio granted Oswaldo Cruz Foundation exclusive development and commercialization rights in Latin America, the Caribbean, and Africa to yellow fever vaccines based on the iBioLaunch plant-based vaccine and protein manufacturing platform

iBio Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Oswaldo Cruz Foundation

Brazil / Non-Profit or Major Disease Foundation

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced